Sfoglia per AUTORE
MORANO F
Collezione AO Ordine Mauriziano

  

Items : 14

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. in BMC cancer / BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6.

2024
AO Ordine Mauriziano

Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; et alii...

Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. in EClinicalMedicine / EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov.

2023
AO Ordine Mauriziano

Leone AG; Casolino R; Trapani D; Miceli R; Massagrande M; Morano F; La Verde N; Dalu D; Berardi R; Marsoni S; Lambertini M; Iula B; Carieri E; Converti M; Di Maio M; Beretta GD; Perrone F; Pietrantonio F; Cinieri S;

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. in Cancer research / Cancer Res. 2023 May 15;83(10):1699-1710. doi: 10.1158/0008-5472.CAN-22-2620.

2023
ASL Alessandria
AO Ordine Mauriziano

Degiuli M; De Manzoni G; Fumagalli U; Antista M; Morano F; Prisciandaro M; Sartore-Bianchi A; Siena S; Musolino A; Llop-Guevara A; Pellegrino B; Serra V; Puliga E; Maina IM; Conticelli D; Migliore C; Moya-Rull D; Ribisi S; Orrù C; Berrino E; Romagnoli D; De Cecco L; Benelli M; Bellomo SE; Pietrantonio F; Rizzolio S; Petrelli A; Baiocchi GL; Amisano MF; et alii...

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology. in ESMO open / ESMO Open. 2023 Jun;8(3):101578. doi: 10.1016/j.esmoop.2023.101578. Epub 2023 Jun 2.

2023
AO Ordine Mauriziano

Leone AG; Miceli R; Trapani D; Massagrande M; Morano F; Marsoni S; La Verde N; Berardi R; Casolino R; Lambertini M; Dalu D; Di Maio M; Beretta GD; Perrone F; Cinieri S; Pietrantonio F;

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Rossi A; Giordano M; Antonuzzo L; Petrelli F; Ratti M; Berenato R; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Fanchini L; Antoniotti C; Bozzarelli S; Sartore-Bianchi A; Lonardi S; Pagani F; Randon G; Prisciandaro M; Raimondi A;

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8.

2022
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pietrantonio F; de Braud F; Milione M; Di Bartolomeo M; Di Maio M; Perrone F; Tamborini E; Brich S; Busico A; Conca E; Capone I; Marmorino F; Calegari MA; Cagnazzo C; Palazzo M; Zaniboni A; Ratti M; Bergamo F; Corti F; Niger M; Racca P; Prisciandaro M; Antonuzzo L; Pella N; Palermo F; Randon G; Murgioni S; Cremolini C; Lonardi S; et alii...

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Bartolomeo M; Pietrantonio F; Di Maio M; Morano F; Corallo S; Berenato R; Ratti M; Clavarezza M; Zaniboni A; Murialdo R; Tampellini M; Ritorto G; Raimondi A; Fucà G; Leone AG; Lonardi S; Antoniotti C; Smiroldo V; Amatu A;

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Loupakis F; Dei Tos AP; Di Maio M; Zagonel V; Lonardi S; Biason P; Borga C; Centonze G; Santini D; Salmaso R; Salvatore L; Aprile G; Calvetti L; Smiroldo V; Rimassa L; Cortiula F; De Maglio G; Morano F; Boccaccino A; Bergamo F; Volante M; Zichi C; Dell'Aquila E; Sperti E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; et alii...

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.

2020
AO Ordine Mauriziano

Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...

A validated prognostic classifier for (V600E)BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Sep;118:121-130. doi: 10.1016/j.ejca.2019.06.008. Epub 2019 Jul 19.

2019
AO Ordine Mauriziano

Loupakis F; Intini R; Cremolini C; Orlandi A; Sartore-Bianchi A; Pietrantonio F; Pella N; Spallanzani A; Dell'Aquila E; Scartozzi M; De Luca E; Rimassa L; Formica V; Leone F; Calvetti L; Aprile G; Antonuzzo L; Urbano F; Prenen H; Negri F; Di Donato S; Buonandi P; Tomasello G; Avallone A; Zustovich F; Moretto R; Antoniotti C; Salvatore L; Calegari MA; et alii...

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer. in British journal of cancer / Br J Cancer. 2019 Oct;121(7):593-599. doi: 10.1038/s41416-019-0560-0. Epub 2019 Sep 2.

2019
AO Ordine Mauriziano

Loupakis F; Biason P; Prete AA; Cremolini C; Pietrantonio F; Pella N; Dell'Aquila E; Sperti E; Zichi C; Intini R; Dadduzio V; Schirripa M; Bergamo F; Antoniotti C; Morano F; Cortiula F; De Maglio G; Rimassa L; Smiroldo V; Calvetti L; Aprile G; Salvatore L; Santini D; Munari G; Salmaso R; Guzzardo V; Mescoli C; Lonardi S; Rugge M; et alii...

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.

2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Fontanini G; Di Maio M; Milione M; Volpi C; Fucà G; Sensi E; Tamburini E; Tampellini M; Baratelli C; Zucchelli G; Busico A; Gloghini A; Rossini D; Perrone F; Tamborini E; Berenato R; Morano F; Moretto R; Cremolini C; De Braud F; Falcone A; Pietrantonio F;